Alec van Gelder/LinkedIn
Dec 5, 2025, 06:04
Alec van Gelder: Expanding Global Support for People with Blood Disorder
Alec van Gelder, Vice President of Corporate Affairs, Rare Disease at Novo Nordisk, shared on LinkedIn:
“Congratulations to the Novo Nordisk Haemophilia and Haemoglobinopathies Foundation as you expand your reach to support even more people living with haemophilia, sickle cell disease, and thalassaemia. Wishing the NNHF Council and team continued success as you amplify your impact and shape a brighter future for patients and communities living with blood disorders worldwide.”
Stay informed with Hemostasis Today.
-
Jun 11, 2026, 08:35Mohamed Reda: CBC Report – More Than Just Numbers
-
Jun 11, 2026, 07:59Uday Sankar Akash Vankayala: Key Findings on IBD-Associated VTE Phenotypes and Inpatient Burden
-
Jun 11, 2026, 07:41Zia Ullah: Hidden Cerebral Venous Sinus Thrombosis After Dengue Recovery
-
Jun 11, 2026, 07:24Aaron Rodriguez Calienes: RESISTANT Registry Provides Reassuring Safety Data for Acute Intracranial Stenting
-
Jun 11, 2026, 07:17Mbunya. S. Misiani: From the WFH Congress to Meaningful Change for Patients with Bleeding Disorders Worldwide
-
Jun 11, 2026, 07:06Bernard Slater Jr.: Hemophilia B Reminds You that No Matter How Strong You Are, You Are Still Human
-
Jun 11, 2026, 05:11Daniel I McIsaac: Less Blood Loss and No Excess VTE with Tranexamic Acid in High-Risk Surgery
-
Jun 11, 2026, 05:03Aymeric Couturier: Lessons from the TRACK Trial on Anticoagulation in Advanced CKD
-
Jun 11, 2026, 04:53Umut Kocabas: Current Practice and Guideline Adherence on Cancer-Associated Thrombosis in Turkey